Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Design, synthesis and antimicrobial studies of some polymyxin analogues

Abstract

To find novel polymycin analogues with high antimicrobial activities and low toxicity, 36 novel polymyxin analogues were synthesized, and in which TZ40-J and TZ40-K were evaluated for their antimicrobial activities using broth microdilution method and for their haemolytic toxicity with sterile sheep blood. Preliminary safety assessments of those two compounds were carried out via the MTT cell viability assay in vitro and acute toxicity assay in vivo. Experimental data demonstrated that TZ40-J and TZ40-K were less toxic and indicate higher activities against Pseudomonas aeruginosa than polymyxin B.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jiang X, et al. Dissemination of antibiotic resistance genes from antibiotic producers to pathogens. Nat Commun. 2017;8:15784.

    Article  CAS  Google Scholar 

  2. Vaara M. Novel derivatives of polymyxins. J Antimicrob Chemother. 2013;68:1213–19.

    Article  CAS  Google Scholar 

  3. Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014;2:145.

    Article  Google Scholar 

  4. Vaara M, Vaara T, Tyrrell JM. Structure–activity studies on polymyxin derivatives carrying three positive charges only reveal a new class of compounds with strong antibacterial activity. Peptides. 2017;91:8–12.

    Article  CAS  Google Scholar 

  5. Calonge N, et al. Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2008;149:43–47.

    Article  Google Scholar 

  6. Velkov T, Thompson PE, Nation RL, Li J. Structure—activity relationships of polymyxin antibiotics. J Med Chem. 2010;53:1898–916.

    Article  CAS  Google Scholar 

  7. Falagas ME, Rafailidis PI. Nephrotoxicity of colistin: new insight into an old antibiotic. Clin Infect Dis. 2009;48:1729–31.

    Article  CAS  Google Scholar 

  8. Antoniadou A, et al. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother. 2007;59:786–90.

    Article  CAS  Google Scholar 

  9. Li J, Rayner CR, Nation RL, Owen RJ, Tan KE, Spelman D. Hetero-resistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006;50:2946–50.

    Article  CAS  Google Scholar 

  10. Garonzik SM, et al. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother. 2011;55:3284–94.

    Article  CAS  Google Scholar 

  11. Roberts KD, Li J, Velkov T, Nation RL, Thompson PE. Antimicrobial polymyxin derivative compounds. AU; WO: 2017054047A1. 2017.

  12. Vaara M, Vaara T. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature. 1983;303:526–8.

    Article  CAS  Google Scholar 

  13. Nikaido H. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985;49:1–32.

    PubMed  PubMed Central  CAS  Google Scholar 

  14. Hancock RE. Antibacterial peptides and the outer membranes of Gram negative bacilli. J Med Microbiol. 1997;46:1–3.

    Article  CAS  Google Scholar 

  15. Hancock RE, Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 1998;16:82–8.

    Article  CAS  Google Scholar 

  16. Thomas CJ, Surolia A. Kinetics of the interaction of endotoxin with polymyxin B and its analogs: a surface plasmon resonance analysis. FEBS Lett. 1999;445:420–4.

    Article  CAS  Google Scholar 

  17. Thomas CJ, Surolia N, Surolia A. Surface plasmon resonance studies resolve the enigmatic endotoxin neutralizing activity of polymyxin B. J Biol Chem. 1999;274:29624–7.

    Article  CAS  Google Scholar 

  18. Bergen PJ, et al. Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new? Diagnostic Microbiol Infect Dis. 2012;74:213–23.

    Article  CAS  Google Scholar 

  19. Zhang Y, Tang HQ, Wang Y, Zhao WJ, Dong YZDesign. Synthesis and antibacterial activity of a group of polymyxin analogues. Chin J Pharm. 2018;10:1378–87.

    Google Scholar 

  20. Tsubery H, Ofek I, Cohen S, Fridkin M. N-terminal modifications of polymyxin nonapeptide and their effect on antibacterial activity. Peptides. 2001;22:1675–81.

    Article  CAS  Google Scholar 

  21. Katsuma N, et al. Development of desfatty acyl-polymyxin B decapeptide analogs with Pseudomonas aeruginosa-specific antimicrobial activity. Chem Pharm Bull. 2009;57:332–6.

    Article  CAS  Google Scholar 

  22. Doymaz MZ, Karaaslan E. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria. Infect Dis. 2019. https://doi.org/10.1080/23744235.2019.1640386.

    Article  CAS  Google Scholar 

  23. Tsubery H. Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. Mol Pharmacol. 2002;62:1036–42.

    Article  CAS  Google Scholar 

  24. Ling LL, et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015;517:455–9.

    Article  CAS  Google Scholar 

  25. CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard-second edition, CLSI documentM-27A2. vol. 22. Wayne, PA: Clinical and Laboratory Standards Institute; 2002.

  26. Bulmus V, Woodward M, Lin L, Murthy N, Stayton P, Hoffman A. A new pH-responsive and glutathione- reactive, endosomal membrane-disruptive polymeric carrier for intracellular delivery of biomolecular drugs. J Control Release. 2003;93:105–20.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Chitai Tianqing Pharmaceutical Group Co. LTD for acute toxicity assay support.

Funding

This work was supported by the Ministry of Science and Technology of the People’s Republic of China, the national key research and development program (program reference: 2017YFD0501404).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun Feng.

Ethics declarations

Conflict of interest

We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, H., Zhang, Y., Ma, J. et al. Design, synthesis and antimicrobial studies of some polymyxin analogues. J Antibiot 73, 158–166 (2020). https://doi.org/10.1038/s41429-019-0262-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-019-0262-0

This article is cited by

Search

Quick links